Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Endocrine Gland Neoplasms × Biopsy, Large-Core Needle × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 7 Thyroid Neoplasms 3 Neoplasm Metastasis 2 Triple Negative Breast Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Hodgkin Disease 1 Endocrine Gland Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Adenoma, Islet Cell 1

Interventions

temsirolimus 1 lutetium Lu 177 dotatate 1 copper dotatate CU-64 1 Valproic Acid 1 Therapeutic Irrigation 1 Sunitinib 1 Staining and Labeling 1 Sirolimus 1 Psilocybin 1 Phlebotomy 1 Lutetium-177 1 Lutetium 1 Irinotecan 1 Immunoglobulin G 1 Gemcitabine 1 Etoposide 1 Disulfides 1 Diffusion 1 Cyclophosphamide 1 Cisplatin 1 Cetuximab 1 Capecitabine 1 Blood Specimen Collection 1 Biopsy, Large-Core Needle 1 Bevacizumab 1 Ascorbic Acid 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07121998 2025-08-14

PROGRESS-TMZ

Uppsala University

Endocrine Gland Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡